Overall Survival Up With Surgical Treatment in T3 Glottic SCC

This article originally appeared here.
Share this content:
Overall Survival Up With Surgical Treatment in T3 Glottic SCC
Overall Survival Up With Surgical Treatment in T3 Glottic SCC

MONDAY, July 11, 2016 (HealthDay News) -- Patients with T3 glottic squamous cell carcinoma (SCC) have improved overall survival (OS) with surgical treatment versus nonsurgical management, according to a study published online July 7 in JAMA Otolaryngology-Head & Neck Surgery.

Maha Al-Gilani, M.B.B.S., from the Washington University School of Medicine in St. Louis, and colleagues compared OS and functional outcomes in a secondary analysis using data from patients with T3 glottic SCC receiving nonsurgical and surgical management.

The researchers found that the five-year OS was 36, 41, and 41 percent, respectively, for nonsurgical management, surgery alone, and surgery plus adjuvant treatment. In multivariable analyses, the adjusted hazard ratios for OS were 0.68 and 0.75 for patients receiving surgery alone versus nonsurgical management and for patients receiving surgery plus adjuvant treatment versus nonsurgical management, respectively. Patients receiving surgery plus nonadjuvant treatment had the highest gastrostomy tube dependence (30.6 percent). Patients receiving chemoradiotherapy had the highest tracheostomy dependence (37 percent).

"Overall survival showed a statistically significant and clinically meaningful improvement in patients with T3 glottic SCC who underwent surgery compared with a nonsurgical treatment," the authors write. "Furthermore, the data suggest that adjuvant and nonsurgical treatment result in a dysfunctional larynx; however, this association needs further study."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease



Sign up for myCME e-newsletters




More in Home

FDA Approves First Generic Under-the-Tongue Suboxone

FDA Approves First Generic Under-the-Tongue Suboxone

May only be prescribed by Drug Addiction Treatment Act-certified prescribers

Kellogg's Honey Smacks Cereal Recalled Due to Salmonella Risk

Kellogg's Honey Smacks Cereal Recalled Due to <i>Salmonella</i> ...

Twenty-four people have been hospitalized, but no deaths have been reported

Portable Music Player Use Linked to Hearing Loss in Children

Portable Music Player Use Linked to Hearing Loss ...

Increased odds of high-frequency hearing loss with portable music player use

is free, fast, and customized just for you!




Already a member?

Sign In Now »